Skip to main content

and
  1. No Access

    Article

    Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor

    Low severity of GVHD, substantial graft vs tumor (GVT) and slow development of protective immunity are well-documented features of cord blood transplants (CBT). We have evaluated the immune reconstitution of adul...

    T Martín-Donaire, M Rico, G Bautista, R Gonzalo-Daganzo in Bone Marrow Transplantation (2009)

  2. No Access

    Article

    Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor

    This open label clinical study provides updated evaluation of the strategy of single unit cord blood transplants (CBTs) with co-infusion of third-party donor (TPD) mobilized hematopoietic stem cells (MHSC). Fi...

    G Bautista, J R Cabrera, C Regidor, R Forés in Bone Marrow Transplantation (2009)

  3. No Access

    Article

    Chagas disease in a recipient of cord blood transplantation

    R Forés, I Sanjuán, F Portero, E Ruiz, C Regidor in Bone Marrow Transplantation (2007)

  4. No Access

    Article

    Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation

    Secondary myelodysplastic syndrome (MDS) and acute leukemia (AL) are well-known complications of antineoplastic therapy. The incidence of these serious complications after autologous hematopoietic transplanta...

    J. Sevilla, A. Rodríguez, D. Hernández-Maraver, J. de Bustos in Annals of Hematology (2002)

  5. No Access

    Article

    Field performance of temporary immersion bioreactor-derived sugarcane plants

    The temporary immersion bioreactor has been found to be an important tool for sugarcane micropropagation, allowing higher shoot formation rates and cost reduction. This research was conducted to demonstrate th...

    J. C. Lorenzo, E. Ojeda, A. Espinosa in In Vitro Cellular & Developmental Biology … (2001)

  6. No Access

    Article

    Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergillosis

    Patients previously diagnosed with invasive aspergillosis (IA) have been considered to be at risk for relapse of mycosis during subsequent hematopoietic transplant. Even with prophylactic measures, reactivati...

    J. Sevilla, D. Hernandez-Maraver, M. Aguado, E. Ojeda, M. Morado in Annals of Hematology (2001)

  7. No Access

    Article

    Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation

    An allogeneic transplantation of CD34+-selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical sibling donors was performed in 50 adult patients with acute myeloid leukemia in first complete remi...

    A Urbano-Ispizua, S Brunet, C Solano, JM Moraleda, M Rovira in Bone Marrow Transplantation (2001)

  8. No Access

    Article

    Sweet's syndrome and accelerated phase of chronic myelogenous leukemia

     Sweet's syndrome is a neutrophilic dermatosis characterized clinically by raised, erythematous, tender lesions on the face, neck, upper thorax and extremities. Several diseases have been associated with this ...

    M. C. Fernández-Jiménez, R. Herraez, E. Ojeda, F. Hernández-Navarro in Annals of Hematology (2000)

  9. No Access

    Article

    A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

    In order to assess the potential clinical benefit of filgrastim (G-CSF) after peripheral blood stem cell (PBSC) autotransplantation a randomized study was begun in our center in July 1997: 62 patients were inv...

    E Ojeda, J Garcia-Bustos, MJ Aguado, R Arrieta, E Quevedo in Bone Marrow Transplantation (1999)

  10. No Access

    Article

    Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study

    We retrospectively compared the incidence and clinical characteristics of cGVHD in 37 allo-PBT recipients transplanted between July 1994 and October 1996 and 37 historical control allo-BMT recipients in a case...

    C Solano, C Martinez, S Brunet, JF Tomás, A Urbano-Ispizua in Bone Marrow Transplantation (1998)

  11. No Access

    Article

    Autotransplantation in chronic myeloid leukemia

    MJ Aguado, F Hernandez-Navarro, JL Bello, E Ojeda in Bone Marrow Transplantation (1998)

  12. No Access

    Article

    Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases

    A simplified cryopreservation method for bone marrow (BM) and peripheral blood progenitor cells (PBPC) was utilized in hematopoietic cell transplantation of 213 patients with hematological or solid neoplasms a...

    F Hernández-Navarro, E Ojeda, R Arrieta, P Ríos-Rull in Bone Marrow Transplantation (1998)

  13. No Access

    Article

    Haematopoietic transplantation in pulmonary alveolar proteinosis associated with chronic myelogenous leukaemia

    Pulmonary alveolar proteinosis (PAP) is a disease of unknown etiopathogenesis sometimes associated with malignant haematological disorders. The potential reversibility of the process in these cases seems to be...

    M Rguez-Luaces, A Lafuente, MP Martín, P Mateos, E Ojeda in Bone Marrow Transplantation (1997)